Zacks Investment Research on MSN

DNLI Posts Narrower-Than-Expected Q3 Loss, Advances MPS IIIA Drug

Denali Therapeutics DNLI reported a third-quarter 2025 loss of 74 cents per share, narrower than the Zacks Consensus Estimate ...
The Grand Junction Daily Sentinel

Trial date moved up for man accused of attacking TV reporter

The trial for a man accused of strangling a TV reporter has been moved up to Dec. 8 to accommodate the victim.